Dysregulation of the alternative complement pathway is strongly implicated in the pathogenesis of complement-mediated kidney diseases (CMKDs). Recent advances are demonstrating that complement proteins, regulators, and genes can inform the etiology, prognosis, and management of these rare diseases and serve as targets for new and emerging therapies. Tune in to this on-demand video for an expert-led discussion centered on the role of the alternative complement pathway in CMKD pathophysiology and how it can be harnessed to prognosticate and treat these progressive diseases. An engaging video animation distills key aspects of this intricate pathway and its relationship with new and emerging treatment targets. Make sure to download the accompanying CMKD Diagnostic Evaluation Quick Reference Guide for a concise summary of disease biomarker analyses as well as an overview of new and emerging agents targeting specific points along the complement system.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/harnessing-alternative-complement-pathway-improve-outcomes-cmkds-targeted
- Start Date: 2024-11-26 06:00:00
- End Date: 2024-11-26 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 44916.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all